Colorectal adenomas with a low frequency of ki-ras mutations: A sample from a population with a low mortality rate from colorectal cancer

Colorectal Disease

Volumn 7, Issue 4, 2005, Pages 323-326

  Kornaros, Stylianos ^a,d   Liloglou, T ^b   Politou, M ^c   Elemenoglou, I ^c  

^a General Hospital Tzanio   (Greece)

^b INSTITUTE OF BIOLOGY   (Greece)

^c TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^d NONE   (Greece)

Author keywords

Colorectal adenomas; Colorectal cancer; Low frequency of ki ras mutations; Low mortality rate

Indexed keywords

RAS PROTEIN;

ARTICLE; CANCER MORTALITY; CODON; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADENOMA; COLORECTAL NEOPLASMS; GENES, RAS; GREECE; HUMANS; POINT MUTATION;

EID: 21244473098     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2005.00809.x     Document Type: Article

References (15)

1. Fearon RE, Hamilton RS, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987; 238: 193-7.
2. Bedenne L, Faivre J, Boutron MC et al. Adenoma-carcinoma sequence or de novo carcinogenesis. A study of adenomatous remnants in a population-based series of large bowel cancer. Cancer 1992; 69: 883-8.
3. Faivre J, Boutron MC, Bataillon P. (1987) Epidemiology of adenoma: clinical data. In: Causation and Prepention of Colorectal Cancer. (eds. Faivre J, Hill MJ), pp. 29-31. Excepta Medica, Amsterdam.
4. Fearon E, Vogelstein B. A Genetic Model for Colorectal Tumorigenesis. Cell 1990; 61: 757-67.
5. Volgestein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Engl J Med 1988; 319: 525-32.
6. Jiang W, Kahn SM, Guillem JG et al. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal and gastric cancer. Oncogene 1989; 4: 923-8.
7. Kumar E, Sukumar S, Barbacid M. Activation of ras Oncogenes Preceding the Onset of Neoplasia. Science 1990; 248: 1101-4.
8. Morris RG, Curtis LJ, Romanowski P, Hardcastle JD et al. Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J Pathol 1996; 180: 357-63.
9. Andreyev HJN, Norman AR, Cunningham D et al. Kirsten ras mutations in patients with colorectal cancer: the 'RAS-CAL II' study. Br J Cancer 2001; 85: 692-6.
10. Maltzman T, Knoll K, Martinez ME et al. Ki-ras Protooncogene Mutations in Sporadic Colorectal Adenomas: Relationship to Histologic and Clinical Characteristics. Gastroenterology 2001; 121: 302-9.
11. Slattery ML, Curtin K, Anderson K et al. Associations between Dietary Intake and Ki-ras Mutations in Colon Tumors: a Population-based Study. Cancer Res 2000; 60: 6935-41.
12. Slattery ML, Anderson K, Curtin K et al. Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutation Res 2001; 483: 73-81.
13. Segal I. Rarity of colorectal adenomas in the African black population. Eur J Cancer Prev 1998; 7: 387-91.
14. Martinez ME, Maltzman T, Marshall JR et al. Risk Factors for Ki-ras Protooncogene Mutation in Sporadic Colorectal Adenomas. Cancer Res 1999; 59: 5181-5.
15. Jackson PE, Hall CN, Badawi AF et al. Freaquency of ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester. Mol Carcinogenesis 1996; 16: 12-9.